Researchers have developed a device that could improve gene therapy delivery to the lungs for people with genetic conditions such…
Articles by Lindsey Shapiro, PhD
In a recent study, scientists described the process through which they discovered GLPG2737, an investigational CFTR modulator considered by…
Treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) led to gains in body mass among cystic fibrosis (CF) patients that were largely…
In lab studies, researchers have identified rare mutations in the CFTR gene — which are the cause of cystic fibrosis…
Doctors should take care not to oversimplify when talking to patients about treatment decisions for chronic illnesses, according to patients,…
Gut bacteria called Bacteroides had anti-inflammatory effects in the blood and airways of a mouse model of cystic fibrosis…
Stopping treatment with inhaled supportive therapies hypertonic saline (HS) or Pulmozyme (dornase alfa) didn’t negatively affect airway mucus…
ReCode Therapeutics has launched a Phase 1 clinical trial to evaluate the safety of RCT2100, its investigational genetic medicine…
Treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor), sold in the U.S. as Trikafta, reduced signs of sinus disease, as seen on MRI…
Adults with cystic fibrosis (CF) make as much use of most routine preventive healthcare services as adults in the…